Product Information

ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $9.9755 per ML under NDC 00548560800. Its NADAC has been published 293 times since Jan 8, 2020.

FDA first approved this application on Mar 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENOXAPARIN 300 MG/3 ML VIAL

enoxaparin sodium
$9.9755per ML

Strength

300 mg/3mL

NDC

00548560800

Classification

Generic

Dosage Form

INJECTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

10/21/2026

Active Ingredients

ENOXAPARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA208600

FDA Approved

3/14/2019

TE Code

AB

On Market Since

11/11/2019

Pharmacological Classes

Heparin
Low-Molecular-Weight
Low Molecular Weight Heparin

Price Statistics

The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 293 times since Jan 8, 2020, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.

Current price$9.9755 per ML
All-time high$23.2005 (Apr 15, 2020)
All-time low$9.8724 (Sep 23, 2026)
52-week high$11.6405
52-week low$9.8724
Median price$12.5053
Average price$12.9416
Largest weekly change-32.2% (Apr 22, 2020)
Weeks tracked293
Tracking sinceJan 8, 2020

Price History

1W

0.0%

1M

+1.0%

3M

+0.5%

6M

-9.1%

1Y

-12.7%

3Y

-25.7%

5Y

-20.2%

All

-57.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Amphastar Pharmaceuticals, Inc., is $9.9755 per ML (NDC 00548560800), effective Nov 11, 2026.

How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?

Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 57.0%. It has been tracked across 293 weekly CMS publications since Jan 8, 2020.

What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?

Since Jan 8, 2020, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8724 (Sep 23, 2026) to a high of $23.2005 (Apr 15, 2020), with a median of $12.5053 per ML.

Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENOXAPARIN 300 MG/3 ML VIAL, is $9.8724 per ML — about 1% below ENOXAPARIN 300 MG/3 ML VIAL.

Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?

ENOXAPARIN 300 MG/3 ML VIAL (NDC 00548560800) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.